Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-hematology Patients Presenting Sepsis (SEPTIFAST)

This study has been completed.
Information provided by:
University Hospital, Grenoble Identifier:
First received: November 20, 2007
Last updated: July 8, 2010
Last verified: July 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2008
  Estimated Primary Completion Date: No date given